The Health Minister of the Democratic Republic of Congo says the deployment of a second Ebola vaccine in the current outbreak won't be a solution to rolling back the disease unless it's matched with other interventions. CGTN's Chris Ocamringa has more.

International health experts and their Congolese counterparts have gathered in Kinshasa to discuss the introduction of a second Ebola vaccine.

The current one being used in the outbreak is produced by US pharmaceutical company Merck. It's proved effective in controlling the spread of the disease, but is reported to be in limited supply. And so manufacturers from Russia, the US and China attended the meeting to make presentations about the efficacy of their vaccines.

YU XUEFENG, CHAIRMAN CANSINO BIOLOGICS INC. "We had those vaccines tested in China and also in West Africa with hundreds of subjects and it demonstrated it's very safe and very immunogenic."

A World Health Organization advisory group had earlier recommended a vaccine made by US firm Johnson and Johnson.

JOHAN VAN HOOF, MANAGING DIRECTOR JOHNSON & JOHNSON "The vaccine is safe to be used specifically also for use in pregnant women and based on the immune response that we see, it's also very likely to be protective and so based on that I feel we are a good candidate."

More than 100,000 people who've come into contact with Ebola patients in North Kivu and Ituri provinces have been vaccinated since the onset of the outbreak last August. But attacks on health workers by armed groups have hampered the containment of the outbreak. The DRC's health minister says the new vaccine wouldn't be a cure all considering the other drawbacks.

OLY ILUNGA DRC'S HEALTH MINISTER "If you want to control and stop this outbreak, it's very important to keep in mind that other pillars like surveillance, contact tracing, Infection Prevention and Control, safe burials, all these pillars are very important and its all these pillars that have helped to contain this outbreak. So the vaccination is a big component but we must not think the vaccine is the solution."

The Ebola response was temporarily interrupted in the eastern town of Beni following two days of insecurity. More than 1500 people have died of Ebola since August last year.

CHRIS OCAMRINGA KINSHASA, DRC "This two-day meeting was meant to share the latest scientific information about the experimental Ebola vaccines that have been produced. The Congolese government will now meet with health experts and make the final decision about whether to introduce another vaccine. Chris Ocamringa, CGTN, Kinshasa, DRC."